COVID-19 Vaccine Development

Our Science
COVID-19 Vaccine Development

COVID-19 Vaccine Development

Rapid progress on the path to develop, test and manufacture a vaccine

Learn more

COVID-19 INFORMATION AND RESOURCES

Your Health
man_lab_dark_380x500.png
man_lab_dark_1000x450_0.jpg

COVID-19 INFORMATION AND RESOURCES

Current information on our scientific progress to bring forward a safe and effective vaccine to help protect against the novel coronavirus.

Learn More

Perspectives on COVID-19 from Mace Rothenberg, M.D.

Your Health
mace_2019_380x500_1.png
mace_2019_1000x450.jpg

Perspectives on COVID-19 from Mace Rothenberg, M.D.

Mace Rothenberg, M.D., Pfizer’s CMO shares some tips about new information and research when it comes to COVID-19.

Learn More

UNDERSTANDING SOCIAL DISTANCING: HOW FAR IS ENOUGH?

Your Health
social_distancing_image_790x500.png
social_distancing_image_1000x450.jpg

UNDERSTANDING SOCIAL DISTANCING: HOW FAR IS ENOUGH?

What is social distancing, and why practice it?

Get more info

Search products

Search products, A–Z

Need help paying for Pfizer medicines?

Find a Trial

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Advanced Search

THE ANTIGEN: #COVID19 PODCAST

Podcasts
the_antigen_image_380x700.png
the_antigen_image_1000x450.jpg

THE ANTIGEN: #COVID19 PODCAST

Season 2 of The Antigen podcast focuses on COVID-19, Pfizer’s response to the crisis and more.

Listen & subscribe here

Maintaining Positivity: A Mother and Daughter’s Perspective on Chronic Pain Due to Osteoarthritis

Your Health
Maintaining_Positivity_790x500.png
Maintaining_Positivity_1000x450.jpg

Maintaining Positivity: A Mother and Daughter’s Perspective on Chronic Pain Due to Osteoarthritis

In recognition of Pain Awareness Month, Ann and her daughter Elizabeth (Lizzie) Sullivan sat down with Grace Whiting, President & CEO of the National Alliance for Caregiving, to discuss the impact that chronic pain due to OA can have.

Learn More

Latest News

Pfizer Investor Day Features Significant Number…

Company has 89 pipeline projects spread across 6 targeted therapeutic areas with 4 programs in registration and 23 in Phase 3 27 key programs highlighted, including assets that could potentially contribute revenue by 2025 and others in the 2026-2028 time frame Pipeline contributes to the Company’s expectation of at least 6% revenue CAGR over the next five years – and delivery of longer-term topline growth beyond that period Major revenue contributions through 2025 anticipated from Oncology,…
Read more